04/18/2024
6:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
8:17 AM | Allarity Therapeutics (Filer)
| Form S-1/A | |
04/15/2024
7:30 AM | Allarity Therapeutics (Filer)
| Form 424B5 | |
04/12/2024
1:10 PM | Allarity Therapeutics (Filer)
| Form 424B5 | |
04/11/2024
12:30 PM | Allarity Therapeutics (Filer)
| Form 424B5 | |
04/09/2024
8:15 AM | Allarity Therapeutics (Filer)
| Form 424B5 | |
04/05/2024
7:30 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/05/2024
7:30 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
4:01 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
8:36 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
7:05 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
8:14 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
7:38 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
6:15 AM | Allarity Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2024
8:45 PM | Allarity Therapeutics (Filer)
| Form DEF 14A | |
03/01/2024
8:21 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:03 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
8:52 AM | 3i, LP (Filed by)
Allarity Therapeutics (Subject)
| Form SC 13G/A | |
02/02/2024
4:03 PM | Allarity Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/01/2024
3:40 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
4:24 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
4:29 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2023
5:30 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
4:00 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
7:30 AM | Allarity Therapeutics (Filer)
| Form S-1/A | |
12/05/2023
6:30 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2023
11:15 PM | Allarity Therapeutics (Filer)
| Form EFFECT | |
11/14/2023
5:05 AM | Allarity Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023
7:35 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2023
8:30 AM | Allarity Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
10/23/2023
4:01 PM | Allarity Therapeutics (Filer)
| Form 424B3 | |
10/19/2023
11:15 PM | Allarity Therapeutics (Filer)
| Form EFFECT | |
09/27/2023
3:30 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2023
7:45 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2023
4:02 PM | Allarity Therapeutics (Issuer)
Benjamin Laura (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2023
2:10 PM | Allarity Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/11/2023
7:15 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2023
8:19 PM | Allarity Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/17/2023
4:10 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2023
4:27 PM | Allarity Therapeutics (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SC 13G | |
07/11/2023
3:05 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad) AI was by far the biggest tech investing trend right now.
But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.
Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…
And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… |
07/07/2023
3:30 PM | Allarity Therapeutics (Filer)
| Form 424B4 | |
07/05/2023
11:15 PM | Allarity Therapeutics (Filer)
| Form EFFECT | |
07/06/2023
5:05 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2023
3:31 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
4:23 PM | Allarity Therapeutics (Filer)
| Form S-1/A | |
06/23/2023
4:05 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
3:45 PM | Allarity Therapeutics (Filer)
| Form DEFA14A | |
06/20/2023
3:30 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2023
5:31 AM | Allarity Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/07/2023
5:31 AM | Allarity Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/06/2023
5:05 AM | Allarity Therapeutics (Filer)
| Form DEF 14A | |
06/01/2023
4:00 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
4:16 PM | Allarity Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2023
5:08 AM | Allarity Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
04/28/2023
5:10 AM | Allarity Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
